Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Surgery Compared With Radiotherapy for Organ-Confined Prostate Cancer

Compares open surgery to remove the prostate with radiation therapy in men with prostate cancer.

Plain-language title generated from the registry record
Registry title: Open Radical Prostatectomy Versus Curative Radiotherapy for Treatment of Organ Confined Prostate Cancer (Retrospective Comparative Study)

Key facts

Where
Sohag, EgyptSee the site

Where in Egypt

  • Sohag UniversitySohag, EgyptNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Sohag University
Trial code
NCT07205783
Record updated
7 April 2026
Original description
In the last few decades not only the diagnosis but also the treatment options for prostate cancer have changed significantly. During this time the surgical procedure of open radical prostatectomy was substantially modified(1,2) and is nowadays considered a safe procedure providing high cancer control rates with low morbidity.(3) The main goal of radical prostatectomy regardless of the approach remains the eradication of cancer while preserving pelvic organ function,whenever possible.(4)Read full original descriptionShow less

Open Radical Prostatectomy Versus Curative Radiotherapy for Treatment of Organ Confined Prostate Cancer (Retrospective Comparative Study)

In the last few decades not only the diagnosis but also the treatment options for prostate cancer have changed significantly. During this time the surgical procedure of open radical prostatectomy was substantially modified(1,2) and is nowadays considered a safe procedure providing high cancer control rates with low morbidity.(3) The main goal of radical prostatectomy regardless of the approach remains the eradication of cancer while preserving pelvic organ function,whenever possible.(4)

Inclusion: Cancer prostate: confirmed by prostate biopsy Cancer stage: T2,T3.

Exclusion: coagulopathy. Pulmonary diseases metastatic tumor.

ClinicalTrials.gov NCT07205783